1
|
Bhattacherjee D, Rahman M, Ghosh S, Bagdi AK, Zyryanov GV, Chupakhin ON, Das P, Hajra A. Advances in Transition‐Metal Catalyzed Carbonylative Suzuki‐Miyaura Coupling Reaction: An Update. Adv Synth Catal 2021. [DOI: 10.1002/adsc.202001509] [Citation(s) in RCA: 20] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Affiliation(s)
- Dhananjay Bhattacherjee
- Department of Organic & Biomolecular Chemistry, Chemical Engineering Institute Ural Federal University 19 Mira Str. 620002 Yekaterinburg Russian Federation
| | - Matiur Rahman
- Department of Organic & Biomolecular Chemistry, Chemical Engineering Institute Ural Federal University 19 Mira Str. 620002 Yekaterinburg Russian Federation
| | - Sumit Ghosh
- Department of Chemistry Visva-Bharati (A Central University) Santiniketan 731235 India
| | - Avik Kumar Bagdi
- Department of Chemistry University of Kalyani Kalyani Nadia-741235 India
| | - Grigory V. Zyryanov
- Department of Organic & Biomolecular Chemistry, Chemical Engineering Institute Ural Federal University 19 Mira Str. 620002 Yekaterinburg Russian Federation
- I. Ya. Postovskiy Institute of Organic Synthesis Ural Division of the Russian Academy of Sciences 22 S. Kovalevskoy Str. Yekaterinburg 620219 Russian Federation
| | - Oleg N. Chupakhin
- Department of Organic & Biomolecular Chemistry, Chemical Engineering Institute Ural Federal University 19 Mira Str. 620002 Yekaterinburg Russian Federation
- I. Ya. Postovskiy Institute of Organic Synthesis Ural Division of the Russian Academy of Sciences 22 S. Kovalevskoy Str. Yekaterinburg 620219 Russian Federation
| | - Pralay Das
- Natural Product Chemistry and Process Development Division CSIR-Institute of Himalayan Bioresource Technology Palampur 176061 H.P India
- Academy of Scientific and Innovative Research New Delhi India
| | - Alakananda Hajra
- Department of Chemistry Visva-Bharati (A Central University) Santiniketan 731235 India
| |
Collapse
|
2
|
Quan H, Wang L, Wang Z, Mei X, Ning J, She D. Application of N‐Acylimidazoles in the Claisen Condensation Reaction. ChemistrySelect 2020. [DOI: 10.1002/slct.202001944] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Affiliation(s)
- Haiyuan Quan
- State Key Laboratory for Biology of Plant Diseases and Insect PestsInstitute of Plant Protection, Chinese Academy of Agricultural Sciences Beijing China
| | - Liuyang Wang
- State Key Laboratory for Biology of Plant Diseases and Insect PestsInstitute of Plant Protection, Chinese Academy of Agricultural Sciences Beijing China
| | - Zhinan Wang
- State Key Laboratory for Biology of Plant Diseases and Insect PestsInstitute of Plant Protection, Chinese Academy of Agricultural Sciences Beijing China
| | - Xiangdong Mei
- State Key Laboratory for Biology of Plant Diseases and Insect PestsInstitute of Plant Protection, Chinese Academy of Agricultural Sciences Beijing China
| | - Jun Ning
- State Key Laboratory for Biology of Plant Diseases and Insect PestsInstitute of Plant Protection, Chinese Academy of Agricultural Sciences Beijing China
| | - Dongmei She
- State Key Laboratory for Biology of Plant Diseases and Insect PestsInstitute of Plant Protection, Chinese Academy of Agricultural Sciences Beijing China
| |
Collapse
|
3
|
Shu B, Wang XT, Shen ZX, Che T, Zhong M, Song JL, Kang HJ, Xie H, Zhang L, Zhang SS. Iridium-catalyzed arylation of sulfoxonium ylides and arylboronic acids: a straightforward preparation of α-aryl ketones. Org Chem Front 2020. [DOI: 10.1039/d0qo00543f] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
A highly efficient iridium(iii)-catalyzed arylation coupling of sulfoxonium ylides with arylboronic acids to generate α-aryl ketones has been established for the first time.
Collapse
Affiliation(s)
- Bing Shu
- Center for Drug Research and Development
- Guangdong Pharmaceutical University
- Guangzhou
- China
- School of Pharmacy
| | - Xiao-Tong Wang
- Center for Drug Research and Development
- Guangdong Pharmaceutical University
- Guangzhou
- China
- School of Pharmacy
| | - Zi-Xuan Shen
- School of Pharmacy
- Guangdong Pharmaceutical University
- Guangzhou
- PR China
| | - Tong Che
- Center for Drug Research and Development
- Guangdong Pharmaceutical University
- Guangzhou
- China
| | - Mei Zhong
- School of Pharmacy
- Guangdong Pharmaceutical University
- Guangzhou
- PR China
| | - Jia-Lin Song
- School of Pharmacy
- Guangdong Pharmaceutical University
- Guangzhou
- PR China
| | - Hua-Jie Kang
- School of Pharmacy
- Guangdong Pharmaceutical University
- Guangzhou
- PR China
| | - Hui Xie
- Center for Drug Research and Development
- Guangdong Pharmaceutical University
- Guangzhou
- China
| | - Luyong Zhang
- Center for Drug Research and Development
- Guangdong Pharmaceutical University
- Guangzhou
- China
- Jiangsu Key Laboratory of Drug Screening
| | - Shang-Shi Zhang
- Center for Drug Research and Development
- Guangdong Pharmaceutical University
- Guangzhou
- China
- Guangzhou Key Laboratory of Construction and Application of New Drug Screening Model Systems
| |
Collapse
|
4
|
Moustafa D, Sweet C, Lim H, Calalpa B, Kaur P. Mn/Cu catalyzed addition of arylboronic acid to nitriles: Direct synthesis of arylketones. Tetrahedron Lett 2018. [DOI: 10.1016/j.tetlet.2018.09.021] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
5
|
Sharma P, Rohilla S, Jain N. Palladium Catalyzed Carbonylative Coupling for Synthesis of Arylketones and Arylesters Using Chloroform as the Carbon Monoxide Source. J Org Chem 2017; 82:1105-1113. [DOI: 10.1021/acs.joc.6b02711] [Citation(s) in RCA: 47] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Poonam Sharma
- Department of Chemistry, Indian Institute of Technology Delhi, New Delhi, India 110016
| | - Sandeep Rohilla
- Department of Chemistry, Indian Institute of Technology Delhi, New Delhi, India 110016
| | - Nidhi Jain
- Department of Chemistry, Indian Institute of Technology Delhi, New Delhi, India 110016
| |
Collapse
|
6
|
Yang L, Liu W, Mei H, Zhang Y, Yu X, Xu Y, Li H, Huang J, Zhao Z. Synthesis and biological evaluation of pentanedioic acid derivatives as farnesyltransferase inhibitors. MEDCHEMCOMM 2015. [DOI: 10.1039/c4md00498a] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
The present study reports a series of novel potent farnesyltransferase inhibitors from chemical modifications of the lead compounds, such as compound 13n with an IC50 value of 0.0029 μM.
Collapse
Affiliation(s)
- Liuqing Yang
- Shanghai Key Laboratory of New Drug Design
- School of Pharmacy
- East China University of Science and Technology
- Shanghai 200237
- China
| | - Wei Liu
- Shanghai Key Laboratory of New Drug Design
- School of Pharmacy
- East China University of Science and Technology
- Shanghai 200237
- China
| | - Hanbing Mei
- Shanghai Key Laboratory of New Drug Design
- School of Pharmacy
- East China University of Science and Technology
- Shanghai 200237
- China
| | - Yuan Zhang
- Shanghai Key Laboratory of New Drug Design
- School of Pharmacy
- East China University of Science and Technology
- Shanghai 200237
- China
| | - Xiaojuan Yu
- Shanghai Key Laboratory of New Drug Design
- School of Pharmacy
- East China University of Science and Technology
- Shanghai 200237
- China
| | - Yufang Xu
- Shanghai Key Laboratory of New Drug Design
- School of Pharmacy
- East China University of Science and Technology
- Shanghai 200237
- China
| | - Honglin Li
- Shanghai Key Laboratory of New Drug Design
- School of Pharmacy
- East China University of Science and Technology
- Shanghai 200237
- China
| | - Jin Huang
- Shanghai Key Laboratory of New Drug Design
- School of Pharmacy
- East China University of Science and Technology
- Shanghai 200237
- China
| | - Zhenjiang Zhao
- Shanghai Key Laboratory of New Drug Design
- School of Pharmacy
- East China University of Science and Technology
- Shanghai 200237
- China
| |
Collapse
|
7
|
Raza Ahsraf A, Akhter Z, Bolte M. (3-Benzoyl-phen-yl)(phen-yl)methanone. Acta Crystallogr Sect E Struct Rep Online 2011; 67:o2432. [PMID: 22059009 PMCID: PMC3200948 DOI: 10.1107/s1600536811033344] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2011] [Accepted: 08/16/2011] [Indexed: 11/10/2022]
Abstract
Mol-ecules of the title compound, C(20)H(14)O(2), show approximate C(s) symmetry with the approximate mirror plane perpendicular to the central ring. The torsion angles about the acyclic bonds are 30.05 (15) and 30.77 (15)° in one half compared to -36.62 (14) and -18.60 (15)° in the other half of the mol-ecule. The central aromatic ring makes dihedral angles of 47.78 (4) and 51.68 (3)° with the two terminal rings.
Collapse
|
8
|
XIE AIHUA, CLARK SHAWNAR, PRASANNA SIVAPRAKASAM, DOERKSEN ROBERTJ. Three-dimensional quantitative structure-farnesyltransferase inhibition analysis for some diaminobenzophenones. J Enzyme Inhib Med Chem 2009; 24:1220-8. [PMID: 19912055 PMCID: PMC10725738 DOI: 10.3109/14756360902781389] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022] Open
Abstract
A 3D-QSAR investigation of 95 diaminobenzophenone yeast farnesyltransferase (FT) inhibitors selected from the work of Schlitzer et al. showed that steric, electrostatic, and hydrophobic properties play key roles in the bioactivity of the series. A CoMFA/CoMSIA combined model using the steric and electrostatic fields of CoMFA together with the hydrophobic field of CoMSIA showed significant improvement in prediction compared with the CoMFA steric and electrostatic fields model. The similarity of the 3D-QSAR field maps for yeast FT inhibition activity (from this work) and for antimalarial activity data (from previous work) and the correlation between those activities are discussed.
Collapse
Affiliation(s)
- AIHUA XIE
- Department of Medicinal Chemistry, School of Pharmacy, University of Mississippi, University, MS, 38677-1848, USA
| | - SHAWNA R. CLARK
- Department of Medicinal Chemistry, School of Pharmacy, University of Mississippi, University, MS, 38677-1848, USA
- Tougaloo College, Jackson, MS, 39174
| | - SIVAPRAKASAM PRASANNA
- Department of Medicinal Chemistry, School of Pharmacy, University of Mississippi, University, MS, 38677-1848, USA
| | - ROBERT J. DOERKSEN
- Department of Medicinal Chemistry, School of Pharmacy, University of Mississippi, University, MS, 38677-1848, USA
- Research Institute of Pharmaceutical Sciences, School of Pharmacy, University of Mississippi
| |
Collapse
|
9
|
Kohring K, Wiesner J, Altenkämper M, Sakowski J, Silber K, Hillebrecht A, Haebel P, Dahse HM, Ortmann R, Jomaa H, Klebe G, Schlitzer M. Development of Benzophenone-Based Farnesyltransferase Inhibitors as Novel Antimalarials. ChemMedChem 2008; 3:1217-31. [DOI: 10.1002/cmdc.200800043] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
10
|
Li C, Liu W, Zhao Z(K. Efficient synthesis of benzophenone derivatives in Lewis acid ionic liquids. CATAL COMMUN 2007. [DOI: 10.1016/j.catcom.2007.02.023] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
11
|
Xie A, Sivaprakasam P, Doerksen RJ. 3D-QSAR analysis of antimalarial farnesyltransferase inhibitors based on a 2,5-diaminobenzophenone scaffold. Bioorg Med Chem 2006; 14:7311-23. [PMID: 16837204 DOI: 10.1016/j.bmc.2006.06.041] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2006] [Revised: 06/20/2006] [Accepted: 06/21/2006] [Indexed: 01/30/2023]
Abstract
With annual death tolls in the millions and emerging resistance to existing drugs, novel therapies are needed against malaria. Wiesner et al. recently developed a novel class of antimalarials derived from farnesyltransferase inhibitors based on a 2,5-diaminobenzophenone scaffold. The compounds displayed a wide range of activity, including submicromolar, against the multi-drug resistant Plasmodium falciparum strain Dd2. In order to investigate quantitatively the local physicochemical properties involved in the interaction between drug and biotarget, we used the 3D-QSAR methods CoMFA and CoMSIA to study some of the series, including the screened lead compound 2,5-bis-acylaminobenzophenone, 28 cinnamic acid derivatives, 29 N-(3-benzoyl-4-tolylacetylaminophenyl)-3-(5-aryl-2-furyl)acrylic acid amides, and 34 N-(4-substituted-amino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides. We found that steric, electrostatic, and hydrophobic properties of substituent groups play key roles in the bioactivity of the series of compounds, while hydrogen bonding interactions show no obvious impact. We built several highly predictive 3D-QSAR models, including a CoMSIA one composed of steric, electrostatic, and hydrophobic fields, with r(2)=0.94, q(2)=0.63, and r(pred)(2)=0.63. The results provide insight for optimization of this class of antimalarials for better activity and may prove helpful for further lead optimization.
Collapse
Affiliation(s)
- Aihua Xie
- Department of Medicinal Chemistry, School of Pharmacy, University of Mississippi, 38677-1848, USA
| | | | | |
Collapse
|
12
|
Esteva MI, Kettler K, Maidana C, Fichera L, Ruiz AM, Bontempi EJ, Andersson B, Dahse HM, Haebel P, Ortmann R, Klebe G, Schlitzer M. Benzophenone-based farnesyltransferase inhibitors with high activity against Trypanosoma cruzi. J Med Chem 2006; 48:7186-91. [PMID: 16279776 DOI: 10.1021/jm050456x] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Less toxic drugs are needed to combat the human parasite Trypanosoma cruzi (Chagas's disease). One novel target for antitrypanosomal drug design is farnesyltransferase. Several farnesyltransferase inhibitors based on the benzophenone scaffold were assayed in vitro and in vivo with the parasite. The common structural feature of all inhibitors is an amino function which can be protonated. Best in vitro activity (LC50 values 1 and 10 nM, respectively) was recorded for the R-phenylalanine derivative 4a and for the N-propylpiperazinyl derivative 2f. These inhibitors showed no cytotoxicity to cells. When tested in vivo, the survival rates of infected animals receiving the inhibitors at 7 mg/kg body weight/day were 80 and 60% at day 115 postinfection, respectively.
Collapse
Affiliation(s)
- Mónica I Esteva
- Instituto Nacional de Parasitología Dr. M. Fatala Chabén, A.N.L.I.S., Dr. Carlos G. Malbrán, 1063 Buenos Aires, Argentina
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Mitsch A, Altenkämper M, Sattler I, Schlitzer M. Non-Thiol Farnesyltransferase Inhibitors: Utilization of the Far Aryl Binding Site by Arylthienylacryloylaminobenzophenones. Arch Pharm (Weinheim) 2005; 338:9-17. [PMID: 15674808 DOI: 10.1002/ardp.200400886] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Abstract
We recently described two novel aryl binding sites of farnesyltransferase. The 4- and 5-arylsubstituted thienylacryloyl moieties turned out as appropriate substituents for our benzophenone-based AAX-peptidomimetic capable for occupying the far aryl binding site.
Collapse
Affiliation(s)
- Andreas Mitsch
- Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marburg, Germany
| | | | | | | |
Collapse
|
14
|
Millet R, Domarkas J, Houssin R, Gilleron P, Goossens JF, Chavatte P, Logé C, Pommery N, Pommery J, Hénichart JP. Potent and Selective Farnesyl Transferase Inhibitors. J Med Chem 2004; 47:6812-20. [PMID: 15615530 DOI: 10.1021/jm030502y] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
We recently described a novel series of CA(1)A(2)X peptidomimetics as farnesyl transferase inhibitors (FTIs). These compounds possess an N-(4-piperidinyl)benzamide scaffold mimicking A(1)A(2) residue. Extensive exploration of structure--activity relationships revealed that replacement of cysteine by substituted benzylimidazoles provided nanomolar FTIs with in vitro activities (18e, IC(50) = 4.60 nM on isolated enzyme, EC(50) = 20.0 nM for growth inhibition on a tumor cell line). The molecular docking of 18e and 19e in the active site of the enzyme provided details of key interactions with the protein and showed that the methionine or phenylalanine residue fits into the aryl binding site.
Collapse
Affiliation(s)
- Régis Millet
- Institut de Chimie Pharmaceutique Albert Lespagnol, EA 2692, Université de Lille 2, BP 83 rue du Professeur Laguesse, 59006 Lille, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Polley MJ, Winkler DA, Burden FR. Broad-Based Quantitative Structure−Activity Relationship Modeling of Potency and Selectivity of Farnesyltransferase Inhibitors Using a Bayesian Regularized Neural Network. J Med Chem 2004; 47:6230-8. [PMID: 15566293 DOI: 10.1021/jm049621j] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
Inhibitors of the enzyme farnesyltransferase show potential as novel anticancer agents. There are many known inhibitors, but efforts to build predictive SAR models have been hampered by the structural diversity and flexibility of inhibitors. We have undertaken for the first time a QSAR study of the potency and selectivity of a large, diverse data set of farnesyltransferase inhibitors. We used novel molecular descriptors based on binned atomic properties and invariants of molecular matrices and a robust, nonlinear QSAR mapping paradigm, the Bayesian regularized neural network. We have built robust QSAR models of farnesyltransferase inhibition, geranylgeranyltransferase inhibition, and in vivo data. We have derived a novel selectivity index that allows us to model potency and selectivity simultaneously and have built robust QSAR models using this index that have the potential to discover new potent and selective inhibitors.
Collapse
Affiliation(s)
- Mitchell J Polley
- Centre for Complexity in Drug Design, CSIRO Molecular Science, Private Bag 10, Clayton South MDC, Clayton 3169, Australia
| | | | | |
Collapse
|
16
|
Guy M, Illarionov P, Gurcha S, Dover L, Gibson K, Smith P, Minnikin D, Besra G. Novel prenyl-linked benzophenone substrate analogues of mycobacterial mannosyltransferases. Biochem J 2004; 382:905-12. [PMID: 15202931 PMCID: PMC1133966 DOI: 10.1042/bj20040911] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2004] [Accepted: 06/17/2004] [Indexed: 11/17/2022]
Abstract
PPM (polyprenol monophosphomannose) has been shown to act as a glycosyl donor in the biosynthesis of the Man (mannose)-rich mycobacterial lipoglycans LM (lipomannan) and LAM (lipoarabinomannan). The Mycobacterium tuberculosis PPM synthase (Mt-Ppm1) catalyses the transfer of Man from GDP-Man to polyprenyl phosphates. The resulting PPM then serves as a donor of Man residues leading to the formation of an alpha(1-->6)LM intermediate through a PPM-dependent alpha(1-->6)mannosyltransferase. In the present study, we prepared a series of ten novel prenyl-related photoactivatable probes based on benzophenone with lipophilic spacers replacing several internal isoprene units. These probes were excellent substrates for the recombinant PPM synthase Mt-Ppm1/D2 and, on photoactivation, several inhibited its activity in vitro. The protection of the PPM synthase activity by a 'natural' C(75) polyprenyl acceptor during phototreatment is consistent with probe-mediated photoinhibition occurring via specific covalent modification of the enzyme active site. In addition, the unique mannosylated derivatives of the photoreactive probes were all donors of Man residues, through a PPM-dependent mycobacterial alpha(1-->6)mannosyltransferase, to a synthetic Manp(1-->6)-Manp-O-C(10:1) disaccharide acceptor (where Manp stands for mannopyranose). Photoactivation of probe 7 led to striking-specific inhibition of the M. smegmatis alpha(1-->6)mannosyltransferase. The present study represents the first application of photoreactive probes to the study of mycobacterial glycosyltransferases involved in LM and LAM biosynthesis. These preliminary findings suggest that the probes will prove useful in investigating the polyprenyl-dependent steps of the complex biosynthetic pathways to the mycobacterial lipoglycans, aiding in the identification of novel glycosyltransferases.
Collapse
Key Words
- benzophenone
- inhibition
- lipoarabinomannan
- mannosyltransferase
- mycobacterial
- photoprobe
- esi–ms, electrospray ionization mass spectrometry
- lam, lipoarabinomannan
- lb, luria–bertani
- lm, lipomannan
- magp, mycolyl–arabinogalactan–peptidoglycan
- man, mannose
- manlam, lam with man caps
- manp, mannopyranose
- pilam, lam with phosphoinositide caps
- pim, phosphatidyl-myo-inositol mannoside
- ppm, polyprenol monophosphomannose
Collapse
Affiliation(s)
- Mark R. Guy
- *School of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K
| | - Petr A. Illarionov
- *School of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K
| | - Sudagar S. Gurcha
- *School of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K
| | - Lynn G. Dover
- *School of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K
| | - Kevin J. C. Gibson
- *School of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K
| | - Paul W. Smith
- †GlaxoSmithKline Research & Development Ltd., New Frontiers Science Park North, Harlow, Essex CM19 5AW, U.K
| | - David E. Minnikin
- *School of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K
| | - Gurdyal S. Besra
- *School of Biosciences, The University of Birmingham, Edgbaston, Birmingham B15 2TT, U.K
| |
Collapse
|
17
|
Mitsch A, Wissner P, Silber K, Haebel P, Sattler I, Klebe G, Schlitzer M. Non-thiol farnesyltransferase inhibitors: N-(4-tolylacetylamino-3-benzoylphenyl)-3-arylfurylacrylic acid amides. Bioorg Med Chem 2004; 12:4585-600. [PMID: 15358286 DOI: 10.1016/j.bmc.2004.07.010] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/16/2004] [Accepted: 07/01/2004] [Indexed: 11/28/2022]
Abstract
We have designed arylfurylacryl-substituted benzophenones as non-thiol farnesyltransferase inhibitors utilizing a novel aryl binding site of farnesyltransferase. These compounds display activity in the low nanomolar range.
Collapse
Affiliation(s)
- Andreas Mitsch
- Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marbacher Weg 6, D-35032 Marburg, Germany
| | | | | | | | | | | | | |
Collapse
|
18
|
|
19
|
Wiesner J, Mitsch A, Jomaa H, Schlitzer M. Structure-activity relationships of novel anti-malarial agents. Part 7: N-(3-benzoyl-4-tolylacetylaminophenyl)-3-(5-aryl-2-furyl)acrylic acid amides with polar moieties. Bioorg Med Chem Lett 2003; 13:2159-61. [PMID: 12798326 DOI: 10.1016/s0960-894x(03)00353-6] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
In a previous report, we have provided evidence that novel anti-malarial compounds based on 2,5-diaminobenzophenone farnesyltransferase inhibitors might benefit from the presence of a polar moiety at the para position of the terminal phenyl of the arylfurylacryloyl partial structure. Here, we demonstrate that different moieties with hydrogen bond acceptor properties lead to equipotent or even improved anti-malarial activity in comparison to the nitro group described before.
Collapse
Affiliation(s)
- Jochen Wiesner
- Biochemisches Institut der Universität Giessen, Friedrichstrasse 24, D-35249, Giessen, Germany
| | | | | | | |
Collapse
|
20
|
Wiesner J, Fucik K, Kettler K, Sakowski J, Ortmann R, Jomaa H, Schlitzer M. Structure-activity relationships of novel anti-malarial agents. Part 6: N-(4-arylpropionylamino-3-benzoylphenyl)-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides. Bioorg Med Chem Lett 2003; 13:1539-41. [PMID: 12699750 DOI: 10.1016/s0960-894x(03)00179-3] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
We have demonstrated that the p-trifluoromethylphenylpropionylamino residue at the 2-position of the core structure leads to an active benzophenone-type anti-malarial agent. The attempt to improve water solubility by introduction of an amino group into the alpha-position of the arylpropionyl residue resulted in decreased activity.
Collapse
Affiliation(s)
- Jochen Wiesner
- Biochemisches Institut der Universitätsklinik Giessen, Friedrichstrasse 24, D-35249 Giessen, Germany
| | | | | | | | | | | | | |
Collapse
|
21
|
Kettler K, Sakowski J, Silber K, Sattler I, Klebe G, Schlitzer M. Non-thiol farnesyltransferase inhibitors: N-(4-acylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2-furyl]acrylic acid amides. Bioorg Med Chem 2003; 11:1521-30. [PMID: 12705292 DOI: 10.1016/s0968-0896(03)00064-6] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Abstract
We have designed the nitrophenylfurylacryl-substituted benzophenone 4f as a non-thiol farnesyltransferase inhibitor utilizing a novel aryl binding site of farnesyltransferase. Variation of the 2-acylamino substituent at the benzophenone core structure of our initial lead 4f yielded several non-thiol farnesyltransferase inhibitors with improved activity. These compounds display activity in the low nanomolar range.
Collapse
Affiliation(s)
- Katja Kettler
- Department für Pharmazie, Ludwig-Maximilians-Universität München, Butenandtstr, München, Germany
| | | | | | | | | | | |
Collapse
|
22
|
Wiesner J, Mitsch A, Wissner P, Krämer O, Jomaa H, Schlitzer M. Structure-activity relationships of novel anti-malarial agents. Part 4: N-(3-benzoyl-4-tolylacetylaminophenyl)-3-(5-aryl-2-furyl)acrylic acid amides. Bioorg Med Chem Lett 2002; 12:2681-3. [PMID: 12217353 DOI: 10.1016/s0960-894x(02)00555-3] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
In a previous report, we have described novel anti-malarial compounds based on a 2,5-diaminobenzophenone scaffold. Here, we have invesigated acryloyl derivatives carrying a biaryl structure consisting of a terminal aryl residue and a central 2-furyl ring. Several compounds were obtained in the series of para-substituted phenylfurylacryloyl derivatives that displayed improved anti-malarial activity in comparison to earlier described derivatives. From the structure-activity relationships it can be deduced that there has to be a lipophilic moiety in the para-position of the terminal phenyl residue. Furthermore, there are indications that, alternatively, activity may benefit from the presence of a polar moiety with hydrogen bond acceptor properties.
Collapse
Affiliation(s)
- Jochen Wiesner
- Biochemisches Institut der Universitätsklinik Giessen, Friedrichstrasse 24, D-35249 Giessen, Germany
| | | | | | | | | | | |
Collapse
|
23
|
Mitsch A, Böhm M, Wissner P, Sattler I, Schlitzer M. Non-thiol farnesyltransferase inhibitors: utilization of an aryl binding site by 5-arylacryloylaminobenzophenones. Bioorg Med Chem 2002; 10:2657-62. [PMID: 12057654 DOI: 10.1016/s0968-0896(02)00088-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
We recently described a novel aryl binding site of farnesyltransferase. The 2-naphthylacryloyl residue was developed as an appropriate substituent for our benzophenone-based AAX-peptidomimetic capable of occupying this binding site, resulting in a non-thiol farnesyltransferase inhibitor with nanomolar activity. The activity of this inhibitor is readily explained on the basis of docking studies which show the 2-naphthyl residue fitting into the aryl binding site.
Collapse
Affiliation(s)
- Andreas Mitsch
- Institut für Pharmazeutische Chemie, Philipps-Universität Marburg, Marbacher Weg 6, D-35032 Marburg, Germany
| | | | | | | | | |
Collapse
|